Experience

NeuAge Institute

• United States
• Higher Education
• 1 - 100 Employee

• President

  • May 2021 - Present

  Training, education and learning solutions for the Pharma and related Industries Training, education and learning solutions for the Pharma and related Industries



University of Toronto - University College

• Canada
• Higher Education
• 1 - 100 Employee

• UofT-UC Principal’s Advisory Committee Member

  • Oct 2020 - Present



Minister's Private Career Colleges Advisory Committee

• Ontario

• Member Board of Advisors

  • Dec 2015 - Present

  Board member of Newly formed Ministry of Training, Colleges and Universities Private Career Colleges Advisor Committee. Providing input about current and emerging issues. Board member of Newly formed Ministry of Training, Colleges and Universities Private Career Colleges Advisor Committee. Providing input about current and emerging issues.



Academy of Applied Pharmaceutical Sciences

• Canada
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• President and Dean of Scientific Affairs

  • Apr 2003 - Present



AAPS-Academy of Applied Pharmaceutical Sciences

• Toronto, Canada Area

• Chief Operating Officer and Dean of Scientific Affairs

  • Apr 2003 - Jan 2015

  AAPS is a Post-Graduate College providing training and education the field of Pharmaceutical and Food Safety, Laboratory, Quality, Regulatory, R&D and Clinical Research. AAPS is a Post-Graduate College providing training and education the field of Pharmaceutical and Food Safety, Laboratory, Quality, Regulatory, R&D and Clinical Research.



Ontario Association of Career Colleges, Ontario Ontario Association of Career Colleges, Ontario

• Ontario Association of Career Colleges, Ontario – elected Board Member

  • Apr 2006 - Apr 2007

  -Developing strategies for having a voice in the design and implementation of Regulations that impact the career college sector -Developing strategies for enhancing the resources needed to advocate for and assist in career college sector growth -Developing strategies to outreach to government and public -Developing strategies to build capacity and increase membership -Developing strategies for having a voice in the design and implementation of Regulations that impact the career college sector -Developing strategies for enhancing the resources needed to advocate for and assist in career college sector growth -Developing strategies to outreach to government and public -Developing strategies to build capacity and increase membership



Bayer

• Chemical Manufacturing
• 700 & Above Employee

• Editor-In-Chief

  • Jan 2000 - Sep 2003

  -Founding member of Canada’s first pharmaceutical industry focussed, broad scope peer reviewed publication with the mission of influencing pharmaceutical industry direction.-Evaluating pharmaceutical industry developments and trends - determining direction and editorial content of the magazine. Established Pharmaceutical Canada as the primer pharmaceutical magazine in Canada. -Business and market development by networking and identifying potential writers, regulators, advertisers and new pharma/biopharma companies. -Developing market strategy for positioning Pharmaceutical Canada by evaluating market competitors and their strategy. -Research different Canadian and international pharma/biopharmaceuticals. Evaluating their performance against set criteria. Established an industry forum where companies like QLT, GenSci, and NuGensis are showcased and presented to the industry.-Obtained high ranking federal government and health Canada officials support through congratulatory letters and attendance in various Pharmaceutical Canada Magazine functions, thus further establishing Pharmaceutical Canada reputation as the primer Canadian pharmaceutical magazine.-Recruited top notch industry executives, academia and government representative for the magazine’s Editorial Advisory Board. -Recruited volunteer representatives to distribute the magazine in the representing pharmaceuticals. Ensured distribution coverage in 85% of pharmaceutical companies, thus minimizing magazine’s distribution costs.-Obtained international presence through Canadian consulates and trade shows, minimizing cost of international distribution Show less

• Technical Associate – Quality Assurance

  • May 1997 - Mar 2000

  -“Out sourcing” project team member - assessed and qualified third party suppliers and vendors for potential outsourcing products.-Evaluated operational procedures and designed new process and workflow, including implementing quality check points and performance metrics.-Audited in-house and third party manufacturing and technical documents, ensuring adherence to GMP and regulatory requirements.



Eli Lilly and Company

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Business Development and Financial Analyst

  • Mar 2002 - Apr 2003

  -New Product Launches and Line Extensions: Financial advisor for all new products and line extensions– assessing resources and timelines required for successful product launch-Managed the R&D budget of the organization. Reviewed the R&D plan for each products and assigned financial and human resources for successful implantation of the R&D objectives-Managed the monthly executive committee board meeting, prepared monthly sales and expense, product launch status, human resources and employee retention reports for the executive board-Performed feasibility studies for product launches including resource estimation and market evaluation Show less

• Quality Control/Quality Assurance - Regulatory and Compliance

  • Mar 2000 - Apr 2002

  -Audited various third party manufacturers and contract laboratories to ensure compliance with Canadian GMP and Lilly’s internal quality policies.-Developed and managed key quality systems such as product complaints, deviations, change controls, and self inspection program.-New Product Launches and Line Extensions: CNS new products and line extension team member – assessing resources and timeline required for manufacturing, quality operations, stability, and third party suppliers. Negotiated successfully with the third party laboratory resulting in launch of new CNS product two weeks ahead of schedule.-Managed product quality complaints – eliminated a two year backlogged product quality complaint within two months time frame.-Managed Stability and Change Control processes. Performed gap analysis resulted in revising operating procedures and improving process efficiency. -Coordinated GMP, quality and regulatory requirements for Lilly’s key CNS products.-Member of Word Wide Stability Working Committee. Benchmarking stability and laboratory activities within Eli Lilly and across the industry. Determining and implementing industry best practices. Show less



Seneca College

• Canada
• Higher Education
• 700 & Above Employee

• Lecturer

  • Sep 2000 - Apr 2003

  -Course Coordinator and Lecturer: Pharmacology and Toxicology including various therapeutic areas and drug development process. -Revamped and designed course outline: materials (texts and relevant readings) current with industry trends and requirements. -Establishing an on line version on the course for distance students. -Course Coordinator and Lecturer: Pharmacology and Toxicology including various therapeutic areas and drug development process. -Revamped and designed course outline: materials (texts and relevant readings) current with industry trends and requirements. -Establishing an on line version on the course for distance students.



Genpharm Inc.

• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Research and Development Analyst

  • Jan 1995 - Feb 1997

  -Evaluated viability of research project based on preliminary stability and research data. -Designed stability protocols and managed R&D stability projects. -Developed and validated analytical methods for testing products in development. -Evaluated viability of research project based on preliminary stability and research data. -Designed stability protocols and managed R&D stability projects. -Developed and validated analytical methods for testing products in development.